Consuming soy foods (such as soy milk, tofu and edamame) and cruciferous vegetables (such as cabbages, kale, collard greens, bok choy, Brussels sprouts, and broccoli) may be associated with a reduction in common side effects ...
Dec 11, 2017
0
25
Statisticians at The University of Texas at Dallas have developed an online tool to help breast cancer patients assess their risk of getting a second breast cancer, providing additional guidance for patients and their doctors ...
Oct 26, 2017
0
0
(HealthDay)—Breast cancer patients who take opioid painkillers are more likely to discontinue an important hormone treatment that helps ensure their survival, researchers report.
Sep 11, 2017
0
3
A new study has found a troubling lack of adherence to a potentially lifesaving treatment regimen among breast cancer patients who take opioids to manage their pain.
Sep 1, 2017
0
1
A new study indicates that cancer patients and survivors have a ready weapon against fatigue and "chemo brain": a brisk walk.
Jul 25, 2017
0
39
A single chemotherapy treatment can result in a significant negative impact on walking gait and balance, putting patients at an increasing risk for falls, according to a new study involving breast cancer patients conducted ...
Jun 8, 2017
0
7
As the nation struggles with soaring health care costs, a new report by RTI International shows that younger women diagnosed with breast cancer face a significant treatment burden.
May 3, 2017
0
1
An analysis of the quality of life of several thousand breast cancer survivors in North Carolina found differences in how black and white women functioned and felt physically and spiritually during treatment and two years ...
Sep 20, 2016
0
1
A recent study by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine revealed that triple-negative breast cancer (TNBC), which has generally been unresponsive to hormone ...
May 23, 2016
0
78
The first clinically-relevant mouse model of human breast cancer to successfully express functional estrogen receptor positive (ER+) adenocarcinomas has been developed by researchers at Lawrence Berkeley National Laboratory ...
Dec 16, 2015
1
71
